These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 18980811

  • 1. Defibrillation threshold testing: is it necessary during implantable cardioverter-defibrillator implantation?
    Liu QM, Bai ZL, Liu ZJ, Li XP, Zhou SH.
    Med Hypotheses; 2009 Feb; 72(2):147-9. PubMed ID: 18980811
    [Abstract] [Full Text] [Related]

  • 2. The dilemma of ICD implant testing.
    Swerdlow CD, Russo AM, Degroot PJ.
    Pacing Clin Electrophysiol; 2007 May; 30(5):675-700. PubMed ID: 17461879
    [Abstract] [Full Text] [Related]

  • 3. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.
    Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy and safety of implantable cardioverter defibrillator avoiding routine defibrillation threshold testing].
    Liu Q, Zhou S, Qi S, Zeng G, Ma X, Huang H.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov 08; 34(11):1132-5. PubMed ID: 19952404
    [Abstract] [Full Text] [Related]

  • 5. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it?
    Calvi V, Dugo D, Capodanno D, Arancio R, Di Grazia A, Liotta C, Puzzangara E, Ragusa A, Arestia A, Tamburino C.
    Am Heart J; 2010 Jan 08; 159(1):98-102. PubMed ID: 20102873
    [Abstract] [Full Text] [Related]

  • 6. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up.
    Bianchi S, Ricci RP, Biscione F, Sgreccia F, Di Belardino N, Rossi P, Giuli S, Grammatico A, De Santo T, Santi E, Merico M, Piccirillo G, Azzolini P, Santini M, Puglisi A.
    Pacing Clin Electrophysiol; 2009 May 08; 32(5):573-8. PubMed ID: 19422577
    [Abstract] [Full Text] [Related]

  • 7. Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough?
    Pires LA, Johnson KM.
    J Cardiovasc Electrophysiol; 2006 Feb 08; 17(2):140-5. PubMed ID: 16533250
    [Abstract] [Full Text] [Related]

  • 8. Is defibrillation testing still necessary? A decision analysis and Markov model.
    Gula LJ, Massel D, Krahn AD, Yee R, Skanes AC, Klein GJ.
    J Cardiovasc Electrophysiol; 2008 Apr 08; 19(4):400-5. PubMed ID: 18298512
    [Abstract] [Full Text] [Related]

  • 9. Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators.
    Lubiński A, Lewicka-Nowak E, Zienciuk A, Królak T, Kempa M, Pazdyga A, Swiatecka G.
    Kardiol Pol; 2005 Apr 08; 62(4):317-28; discussion 329-31. PubMed ID: 15928737
    [Abstract] [Full Text] [Related]

  • 10. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.
    Leong-Sit P, Gula LJ, Diamantouros P, Krahn AD, Skanes AC, Yee R, Klein GJ.
    Am Heart J; 2006 Dec 08; 152(6):1104-8. PubMed ID: 17161062
    [Abstract] [Full Text] [Related]

  • 11. High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems.
    Day JD, Olshansky B, Moore S, Brown S, Stolen KQ, Lerew DR, INTRINSIC RV Study Investigators.
    Europace; 2008 Mar 08; 10(3):347-50. PubMed ID: 18308755
    [Abstract] [Full Text] [Related]

  • 12. Is defibrillation testing required for defibrillator implantation?
    Strickberger SA, Klein GJ.
    J Am Coll Cardiol; 2004 Jul 07; 44(1):88-91. PubMed ID: 15234413
    [Abstract] [Full Text] [Related]

  • 13. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.
    Sadoul N, Defaye P, Mouton E, Bizeau O, Dupuis JM, Blangy H, Delarche N, Blanc JJ, Lazarus A, LEADER registry investigators.
    Arch Cardiovasc Dis; 2013 Nov 07; 106(11):562-9. PubMed ID: 24200925
    [Abstract] [Full Text] [Related]

  • 14. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A, Lewicka-Nowak E, Zienciuk A, Królak T, Kempa M, Pazdyga A, Raczak G, Swiatecka G.
    Kardiol Pol; 2005 Sep 07; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [Abstract] [Full Text] [Related]

  • 15. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
    Kirilmaz A, Dokumaci B, Uzun M, Kilicaslan F, Dinckal MH, Yucel O, Karaca M.
    Pacing Clin Electrophysiol; 2005 Jun 07; 28(6):498-505. PubMed ID: 15955181
    [Abstract] [Full Text] [Related]

  • 16. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator.
    Zienciuk A, Lubiński A, Królak T, Lewicka-Nowak E, Kempa M, Pazdyga A, Raczak G.
    Kardiol Pol; 2007 May 07; 65(5):495-500; discussion 501-2. PubMed ID: 17577846
    [Abstract] [Full Text] [Related]

  • 17. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ, MADIT II Study Investigators.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):98-107. PubMed ID: 16386671
    [Abstract] [Full Text] [Related]

  • 18. Defibrillation testing during implantable cardioverter-defibrillator implantation in Italian current practice: the Assessment of Long-term Induction clinical ValuE (ALIVE) project.
    Stefano B, Pietro RR, Maurizio G, Maurizio L, Renato M, Maurizio L, Pietro R, Alessandro P, Gianluca B, Monica M, Sergio C, Massimo S.
    Am Heart J; 2011 Aug 03; 162(2):390-7. PubMed ID: 21835302
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Utility of routine follow-up defibrillator threshold testing in congenital heart disease and pediatric populations.
    Stephenson EA, Cecchin F, Walsh EP, Berul CI.
    J Cardiovasc Electrophysiol; 2005 Jan 03; 16(1):69-73. PubMed ID: 15673391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.